Integra LifeSciences Holdings Corp (Nasdaq:IART) made a public announcement about the launch of Integra™ Allograft Cancellous Sponge.
Integra LifeSciences Holdings Corp (Nasdaq:IART) made a public announcement about the launch of Integra™ Allograft Cancellous Sponge, a compressible bone graft composed of 100% cancellous bone. The best part of this cancellous sponge is that fluids like saline, blood or bone marrow aspirate can be easily absorbed it; additionally, it is possible to compress this sponge to half its size after rehydration.
The cancellous sponge affords excellent surgical flexibility. "The unique handling characteristics and biocompatibility of Integra™ Allograft Cancellous Sponge make it an ideal addition to Integra's portfolio of allografts and orthobiologics, and provide another flexible solution for improving patient care," said Bill Weber, Vice President of Integra OrthoBiologics.
Source-Medindia